BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7931327)

  • 1. Bimodal opioid regulation of cyclic AMP formation: implications for positive and negative coupling of opiate receptors to adenylyl cyclase.
    Wang L; Gintzler AR
    J Neurochem; 1994 Nov; 63(5):1726-30. PubMed ID: 7931327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine tolerance and physical dependence: reversal of opioid inhibition to enhancement of cyclic AMP formation.
    Wang L; Gintzler AR
    J Neurochem; 1995 Mar; 64(3):1102-6. PubMed ID: 7861140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids can enhance and inhibit the electrically evoked release of methionine-enkephalin.
    Xu H; Smolens I; Gintzler AR
    Brain Res; 1989 Dec; 504(1):36-42. PubMed ID: 2574620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptors and inhibition of dopamine-sensitive adenylate cyclase in slices of rat brain regions receiving a dense dopaminergic input.
    Heijna MH; Bakker JM; Hogenboom F; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1992 Dec; 229(2-3):197-202. PubMed ID: 1337044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mu and delta opiate receptors in neuronal and astroglial primary cultures from various regions of the brain--coupling with adenylate cyclase, localisation on the same neurones and association with dopamine (D1) receptor adenylate cyclase.
    Eriksson PS; Hansson E; Rönnbäck L
    Neuropharmacology; 1991 Nov; 30(11):1233-9. PubMed ID: 1663598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered mu-opiate receptor-G protein signal transduction following chronic morphine exposure.
    Wang L; Gintzler AR
    J Neurochem; 1997 Jan; 68(1):248-54. PubMed ID: 8978732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
    J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired coupling of naloxone sensitive opiate receptors to adenylate cyclase in PMNLs of aged male subjects.
    Fulop T; Kekessy D; Foris G
    Int J Immunopharmacol; 1987; 9(6):651-7. PubMed ID: 2826349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid-controlled adenylate cyclase in the guinea-pig myenteric plexus is confined to nerve somata.
    Rengel I; Sinowatz F; Schulz R
    Eur J Pharmacol; 1992 Dec; 227(4):385-90. PubMed ID: 1332873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD; Medzihradsky F
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4062-6. PubMed ID: 8097884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different G proteins mediate the opioid inhibition or enhancement of evoked [5-methionine]enkephalin release.
    Gintzler AR; Xu H
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4741-5. PubMed ID: 1828885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of phosphorylation state to opioid responsiveness in opiate naive and tolerant/dependent tissue.
    Wang L; Medina VM; Rivera M; Gintzler AR
    Brain Res; 1996 Jun; 723(1-2):61-9. PubMed ID: 8813382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine 3':5'-cyclic monophosphate (cAMP) is not the mediator of kappa opiate effect on human placental lactogen release.
    Petit A; Gallo-Payet N; Lehoux JG; Bellabarba D; Bélisle S
    Life Sci; 1991; 49(6):465-72. PubMed ID: 1650874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid enhancement of evoked [Met5]enkephalin release requires activation of cholinergic receptors: possible involvement of intracellular calcium.
    Xu H; Gintzler AR
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1978-82. PubMed ID: 1311858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling.
    Yabaluri N; Medzihradsky F
    Mol Pharmacol; 1997 Nov; 52(5):896-902. PubMed ID: 9351981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins.
    Chan JS; Chiu TT; Wong YH
    J Neurochem; 1995 Dec; 65(6):2682-9. PubMed ID: 7595566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid-inhibited adenylyl cyclase in rat brain membranes: lack of correlation with high-affinity opioid receptor binding sites.
    Nijssen PC; Sexton T; Childers SR
    J Neurochem; 1992 Dec; 59(6):2251-62. PubMed ID: 1331327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
    Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
    Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS; Tallman JF; Nestler EJ
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.